Optimi Health Corp. (OPTH)
NasdaqCM: OPTH
· Real-Time Price · USD
4.74
+0.06 (1.28%)
At close: Aug 12, 2026, 3:59 PM
4.85
+2.32%
After-hours: 4:10 PM
Optimi Health Corp. (OPTH) Stock Price, Analysis & Data
1.28% (1D)
| Bid | 4.65 |
| Market Cap | 27.14M |
| Revenue (ttm) | 231.86K |
| Net Income (ttm) | -5.4M |
| Beta | 1.60 |
| EPS (ttm) | -1.23 |
| PE Ratio (ttm) | n/a |
| Forward PE | n/a |
| P/B (ttm) | 6.08 |
| P/S (ttm) | 117.06 |
| Earnings Date | n/a |
| Ask | 4.73 |
| Volume | 7,280 |
| Avg. Volume (20D) | 156,596 |
| Open | 4.87 |
| Previous Close | 4.68 |
| Day's Range | 4.55 - 4.87 |
| 52-Week Range | 4.00 - 6.40 |
| Analyst | n/a |
| Price Target | n/a |
| Dividends | n/a |
| Ex-Dividend Date | n/a |
About OPTH
Optimi Health Corp. operates as a pharmaceutical and nutraceutical drug manufacturing company in Canada. The company manufactures controlled substances including finished MDMA and psilocybin drug products, supplying them directly to authorized clinics, pharmacies, clinical trials, and partners. The company produces and supplies MDMA, natural psilocybin, psilocin, other psychedelic substances, and functional mushrooms derived from botanical source...
Sector Healthcare
IPO Date May 20, 2026
Employees n/a
Stock Exchange NasdaqCM
Ticker Symbol OPTH
Website https://www.optimihealth.ca
Financial Performance
In 2025, Optimi Health's revenue was 426.3K, an increase of 9.35% compared to the previous year's 389.85K. Earnings were -3.71M, a decrease of -38.5%.
Financial Statements
